Skip to main content
Top
Published in: Obesity Surgery 8/2019

01-08-2019 | Obesity | Original Contributions

Serum Bile Acid Levels Before and After Sleeve Gastrectomy and Their Correlation with Obesity-Related Comorbidities

Authors: Stefano De Vuono, Maria Anastasia Ricci, Elisa Nulli Migliola, Maria Chiara Monti, Elva Morretta, Marcello Boni, Stefano Ministrini, Adriana Carino, Stefano Fiorucci, Eleonora Distrutti, Graziana Lupattelli

Published in: Obesity Surgery | Issue 8/2019

Login to get access

Abstract

Background and Aims

The rising prevalence of morbid obesity is increasing the demand for bariatric surgery. The benefits observed after bariatric surgery seems to be not fully explained by surgery-induced weight loss or traditional cardiovascular risk factors regression or improvement. Some evidences suggest that bile acid (BA) levels change after bariatric surgery, thus suggesting that BA concentrations could influence some of the metabolic improvement induced by bariatric surgery. In this report, we have characterized circulating BA patterns and compared them to metabolic and vascular parameters before and after sleeve gastrectomy (SG).

Patients and Methods

Seventy-nine subjects (27 males, 52 females, aged 45 ± 12 years, mean BMI 45 ± 7 kg/m2) SG candidates were included in the study. Before and about 12 months after SG, all subjects underwent a clinical examination, blood tests (including lipid profile, plasma glucose and insulin, both used for calculating HOMA-IR, and glycated hemoglobin), ultrasound visceral fat area estimation, ultrasound flow-mediated dilation evaluation, and determination of plasma BA concentrations.

Results

Before SG, both primary and secondary BA levels were higher in insulin-resistant obese subjects than in non-insulin resistant obese, and BA were positively associated with the markers of insulin-resistance. After SG, total (conjugated and unconjugated) cholic acids significantly decreased (p 0.007), and total lithocholic acids significantly increased (p 0.017). SG-induced total cholic and chenodeoxycholic acid changes were directly associated with surgery-induced glycemia (p 0.011 and 0.033 respectively) and HOMA-IR (p 0.016 and 0.012 respectively) changes.

Conclusions

Serum BA are associated with glucose metabolism and particularly with markers of insulin-resistance. SG modifies circulating BA pool size and composition. SG-induced BA changes are associated with insulin-resistance amelioration. In conclusion, an interplay between glucose metabolism and circulating BA exists but further studies are needed.
Appendix
Available only for authorised users
Literature
1.
go back to reference NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016;387(10026):1377–96.CrossRef NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Lancet. 2016;387(10026):1377–96.CrossRef
2.
go back to reference Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363(23):2211–9.CrossRef Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363(23):2211–9.CrossRef
3.
go back to reference Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015;25(10):1822–32.CrossRef Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015;25(10):1822–32.CrossRef
4.
go back to reference Sjöström L, Peltonen J, Jacobson P, et al. Swedish obese subjects study. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307:56–65.CrossRef Sjöström L, Peltonen J, Jacobson P, et al. Swedish obese subjects study. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307:56–65.CrossRef
5.
go back to reference Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444(7121):875–80.CrossRef Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444(7121):875–80.CrossRef
6.
go back to reference Ricci MA, Ministrini S, De Vuono S, et al. Sleeve gastrectomy efficacy on metabolic and cardiovascular dysfunction with a focus on the role of comorbidities. Angiology. 2018;69(6):475–82.CrossRef Ricci MA, Ministrini S, De Vuono S, et al. Sleeve gastrectomy efficacy on metabolic and cardiovascular dysfunction with a focus on the role of comorbidities. Angiology. 2018;69(6):475–82.CrossRef
7.
go back to reference Lakka TA, Lakka HM, Salonen R, et al. Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men. Atherosclerosis. 2001;154:497–504.CrossRef Lakka TA, Lakka HM, Salonen R, et al. Abdominal obesity is associated with accelerated progression of carotid atherosclerosis in men. Atherosclerosis. 2001;154:497–504.CrossRef
8.
go back to reference Ouchi N, Parker JL, Lugus JJ, et al. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85–97.CrossRef Ouchi N, Parker JL, Lugus JJ, et al. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85–97.CrossRef
9.
go back to reference Smith SR, Wilson PW. Free fatty acids and atherosclerosis — guilty or innocent? J Clin Endocrinol Metab. 2006;91:2506–8.CrossRef Smith SR, Wilson PW. Free fatty acids and atherosclerosis — guilty or innocent? J Clin Endocrinol Metab. 2006;91:2506–8.CrossRef
10.
go back to reference Fiorucci S, Mencarelli A, Palladino G, et al. Bile-acid activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders. Trends Pharmacol Sci. 2009;30:570–80.CrossRef Fiorucci S, Mencarelli A, Palladino G, et al. Bile-acid activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders. Trends Pharmacol Sci. 2009;30:570–80.CrossRef
11.
go back to reference Fiorucci S, Distrutti E. Bile acid-activated receptors, intestinal microbiota, and the treatment of metabolic disorders. Trends Mol Med. 2015;21:702–14.CrossRef Fiorucci S, Distrutti E. Bile acid-activated receptors, intestinal microbiota, and the treatment of metabolic disorders. Trends Mol Med. 2015;21:702–14.CrossRef
12.
go back to reference Kaska L, Sledzinski T, Chomiczewska A, et al. Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome. World J Gastroenterol. 2016;22(39):8698–719.CrossRef Kaska L, Sledzinski T, Chomiczewska A, et al. Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome. World J Gastroenterol. 2016;22(39):8698–719.CrossRef
13.
go back to reference Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.CrossRef Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.CrossRef
14.
go back to reference Hirooka M, Kumagi T, Kurose K, et al. A technique for the measurement of visceral fat by ultrasonography: comparison of measurements by ultrasonography and computed tomography. Intern Med. 2005;44:794–9.CrossRef Hirooka M, Kumagi T, Kurose K, et al. A technique for the measurement of visceral fat by ultrasonography: comparison of measurements by ultrasonography and computed tomography. Intern Med. 2005;44:794–9.CrossRef
15.
go back to reference Lekakis J, Abraham P, Balbarini A, et al. Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation. Eur J Cardiovasc Prev Rehabil. 2011;18:775–89.CrossRef Lekakis J, Abraham P, Balbarini A, et al. Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation. Eur J Cardiovasc Prev Rehabil. 2011;18:775–89.CrossRef
16.
go back to reference Cariou B, Chetiveaux M, Zaïr Y, et al. Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults. Nutr Metab (Lond). 2011;8(1):48.CrossRef Cariou B, Chetiveaux M, Zaïr Y, et al. Fasting plasma chenodeoxycholic acid and cholic acid concentrations are inversely correlated with insulin sensitivity in adults. Nutr Metab (Lond). 2011;8(1):48.CrossRef
17.
go back to reference Haeusler RA, Astiarraga B, Camastra S, et al. Human insulin resistance is associated with increased plasma levels of 12alphahydroxylated bile acids. Diabetes. 2013;62(12):4184–91.CrossRef Haeusler RA, Astiarraga B, Camastra S, et al. Human insulin resistance is associated with increased plasma levels of 12alphahydroxylated bile acids. Diabetes. 2013;62(12):4184–91.CrossRef
18.
go back to reference Wewalka M, Patti ME, Barbato C, et al. Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulin. J Clin Endocrinol Metab. 2014;99(4):1442–51.CrossRef Wewalka M, Patti ME, Barbato C, et al. Fasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulin. J Clin Endocrinol Metab. 2014;99(4):1442–51.CrossRef
19.
go back to reference Steinert RE, Peterli R, Keller S, et al. Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial. Obesity. 2013;21:E660–8.CrossRef Steinert RE, Peterli R, Keller S, et al. Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial. Obesity. 2013;21:E660–8.CrossRef
20.
go back to reference Patti M-E, Houten SM, Bianco AC, et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity. 2009;17:1671–7.CrossRef Patti M-E, Houten SM, Bianco AC, et al. Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism. Obesity. 2009;17:1671–7.CrossRef
21.
go back to reference Belgaumkar AP, Vincent RP, Carswell KA, et al. Changes in bile acid profile after laparoscopic sleeve gastrectomy are associated with improvements in metabolic profile and fatty liver disease. Obes Surg. 2016;26:1195–202.CrossRef Belgaumkar AP, Vincent RP, Carswell KA, et al. Changes in bile acid profile after laparoscopic sleeve gastrectomy are associated with improvements in metabolic profile and fatty liver disease. Obes Surg. 2016;26:1195–202.CrossRef
22.
go back to reference Haluzíková D, Lacinová Z, Kaválková P, et al. Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects. Obesity (Silver Spring). 2013;21:1335–42.CrossRef Haluzíková D, Lacinová Z, Kaválková P, et al. Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects. Obesity (Silver Spring). 2013;21:1335–42.CrossRef
23.
go back to reference Nakatani H, Kasama K, Oshiro T, et al. Serum bile acid along with plasma incretins and serum highmolecular weight adiponectin levels are increased after bariatric surgery. Metabolism. 2009;58(10):1400–7.CrossRef Nakatani H, Kasama K, Oshiro T, et al. Serum bile acid along with plasma incretins and serum highmolecular weight adiponectin levels are increased after bariatric surgery. Metabolism. 2009;58(10):1400–7.CrossRef
25.
go back to reference Li T, Chiang JY. Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev. 2014;66:948–83.CrossRef Li T, Chiang JY. Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev. 2014;66:948–83.CrossRef
26.
go back to reference Prawitt J, Caron S, Staels B. Bile acid metabolism and the pathogenesis of type 2 diabetes. Curr Diab Rep. 2011;11:160–6.CrossRef Prawitt J, Caron S, Staels B. Bile acid metabolism and the pathogenesis of type 2 diabetes. Curr Diab Rep. 2011;11:160–6.CrossRef
27.
go back to reference Staels B, Prawitt J. Soaping up type 2 diabetes with bile acids?: the link between glucose and bile acid metabolism in humans tightens: quality matters. Diabetes. 2013;62(12):3987–9.CrossRef Staels B, Prawitt J. Soaping up type 2 diabetes with bile acids?: the link between glucose and bile acid metabolism in humans tightens: quality matters. Diabetes. 2013;62(12):3987–9.CrossRef
28.
go back to reference Trung VN, Yamamoto H, Furukawa A, et al. Enhanced intestinal motility during oral glucose tolerance test after laparoscopic sleeve gastrectomy: preliminary results using cine magnetic resonance imaging. PLoS One. 2013;8(6):e65739.CrossRef Trung VN, Yamamoto H, Furukawa A, et al. Enhanced intestinal motility during oral glucose tolerance test after laparoscopic sleeve gastrectomy: preliminary results using cine magnetic resonance imaging. PLoS One. 2013;8(6):e65739.CrossRef
29.
go back to reference Aron-Wisnewsky J, Clement K. The effects of gastrointestinal surgery on gut microbiota: potential contribution to improved insulin sensitivity. Curr Atheroscler Rep. 2014;16:454.CrossRef Aron-Wisnewsky J, Clement K. The effects of gastrointestinal surgery on gut microbiota: potential contribution to improved insulin sensitivity. Curr Atheroscler Rep. 2014;16:454.CrossRef
30.
go back to reference Bomzon A, Ljubuncic P. Bile acids as endogenous vasodilators. Biochem Pharmacol. 1995;49:581–9.CrossRef Bomzon A, Ljubuncic P. Bile acids as endogenous vasodilators. Biochem Pharmacol. 1995;49:581–9.CrossRef
31.
go back to reference Walsh LK, Restaino RM, Neuringer M, et al. Administration of tauroursodeoxycholic acid prevents endothelial dysfunction caused by an oral glucose load. Clin Sci (Lond). 2016;130(21):1881–8.CrossRef Walsh LK, Restaino RM, Neuringer M, et al. Administration of tauroursodeoxycholic acid prevents endothelial dysfunction caused by an oral glucose load. Clin Sci (Lond). 2016;130(21):1881–8.CrossRef
32.
go back to reference Battson ML, Lee DM, Jarrell DK, et al. Tauroursodeoxycholic acid reduces arterial stiffness and improves endothelial dysfunction in type 2 diabetic mice. J Vasc Res. 2017;54(5):280–7.CrossRef Battson ML, Lee DM, Jarrell DK, et al. Tauroursodeoxycholic acid reduces arterial stiffness and improves endothelial dysfunction in type 2 diabetic mice. J Vasc Res. 2017;54(5):280–7.CrossRef
33.
go back to reference Sinisalo J, Vanhanen H, Pajunen P, et al. Ursodeoxycholic acid and endothelial-dependent, nitric oxide-independent vasodilatation of forearm resistance arteries in patients with coronary heart disease. Br J Clin Pharmacol. 1999;47(6):661–5.CrossRef Sinisalo J, Vanhanen H, Pajunen P, et al. Ursodeoxycholic acid and endothelial-dependent, nitric oxide-independent vasodilatation of forearm resistance arteries in patients with coronary heart disease. Br J Clin Pharmacol. 1999;47(6):661–5.CrossRef
34.
go back to reference Chung J, Kim KH, Lee SC, et al. Ursodeoxycholic acid (UDCA) exerts anti-atherogenic effects by inhibiting endoplasmic reticulum (ER) stress induced by disturbed flow. Mol Cells. 2015;38(10):851–8.CrossRef Chung J, Kim KH, Lee SC, et al. Ursodeoxycholic acid (UDCA) exerts anti-atherogenic effects by inhibiting endoplasmic reticulum (ER) stress induced by disturbed flow. Mol Cells. 2015;38(10):851–8.CrossRef
35.
go back to reference Kim SY, Kwon YW, Jung IL, et al. Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK via PKCalpha-mediated MKP-1 induction. Cardiovasc Res. 2011;92:307–16.CrossRef Kim SY, Kwon YW, Jung IL, et al. Tauroursodeoxycholate (TUDCA) inhibits neointimal hyperplasia by suppression of ERK via PKCalpha-mediated MKP-1 induction. Cardiovasc Res. 2011;92:307–16.CrossRef
36.
go back to reference Ma J, Iida H, Jo T, et al. Ursodeoxycholic acid inhibits endothelin-1 production in human vascular endothelial cells. Eur J Pharmacol. 2004;505:67–74.CrossRef Ma J, Iida H, Jo T, et al. Ursodeoxycholic acid inhibits endothelin-1 production in human vascular endothelial cells. Eur J Pharmacol. 2004;505:67–74.CrossRef
Metadata
Title
Serum Bile Acid Levels Before and After Sleeve Gastrectomy and Their Correlation with Obesity-Related Comorbidities
Authors
Stefano De Vuono
Maria Anastasia Ricci
Elisa Nulli Migliola
Maria Chiara Monti
Elva Morretta
Marcello Boni
Stefano Ministrini
Adriana Carino
Stefano Fiorucci
Eleonora Distrutti
Graziana Lupattelli
Publication date
01-08-2019
Publisher
Springer US
Published in
Obesity Surgery / Issue 8/2019
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-019-03877-6

Other articles of this Issue 8/2019

Obesity Surgery 8/2019 Go to the issue